CME Group Inc. - (CME): Price and Financial Metrics
CME Group Inc. - (CME)
Today's Latest Price: $163.34 USD
Updated Oct 19 6:13pm
Add CME to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 5 in Financial Marketplaces
See all "A" rated Strong Buy stocks
CME Stock Summary
- CME has a market capitalization of $60,245,422,317 -- more than approximately 96.79% of US stocks.
- The ratio of debt to operating expenses for Cme Group Inc is higher than it is for about 97.99% of US stocks.
- In terms of volatility of its share price, CME is more volatile than just 8.47% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Cme Group Inc, a group of peers worth examining would be BNS, WBK, BCS, GS, and SC.
- Visit CME's SEC page to see the company's official filings. To visit the company's web site, go to www.cmegroup.com.
CME Stock Price Chart Interactive Chart >
CME Price/Volume Stats
| Current price | $163.34 | 52-week high | $225.36 |
| Prev. close | $167.99 | 52-week low | $131.80 |
| Day low | $163.26 | Volume | 1,283,725 |
| Day high | $168.80 | Avg. volume | 1,961,242 |
| 50-day MA | $169.55 | Dividend yield | 2.02% |
| 200-day MA | $180.97 | Market Cap | 58.58B |
CME Group Inc. - (CME) Company Bio
CME Group operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products for trading and/or clearing across various asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals. The company was founded in 1898 and is based in Chicago, Illinois.
CME Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $163.34 | $262.19 | 56% |
We started the process of determining a valid price forecast for Cme Group Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Cme Group Inc ranked in the 57th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 57%. As for the metrics that stood out in our discounted cash flow analysis of Cme Group Inc, consider:
- 42% of the company's capital comes from equity, which is greater than merely 20.9% of stocks in our cash flow based forecasting set.
- Cme Group Inc's weighted average cost of capital (WACC) is 6%; for context, that number is higher than only 0.65% of tickers in our DCF set.
- The company's cost of debt, derived from its interest coverage, tax rate, and market capitalization, is greater than only 0% of stocks in its sector (Financial Services).
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 53% |
| 1% | 55% |
| 2% | 56% |
| 3% | 58% |
| 4% | 59% |
| 5% | 61% |
Want more companies with a valuation profile/forecast similar to that of Cme Group Inc? See GHL, DFIN, GBL, AMG, and NGHC.
Loading social stream, please wait...